YHD1119
As of the edition of 20 October 2026, YHD1119 is a drug known only by a code name: of no established status; acts on CACNA1A, CACNA1B and CACNA1C and 23 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Status not established
- Kind
- Code name only
- Registered trials
- 2, 0 stopped early
- Disease areas
- Nervous system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
| Gene | Protein | UniProt |
|---|---|---|
| CACNB4 | Voltage-dependent L-type calcium channel subunit beta-4 | O00305 |
| CACNA1A | Voltage-dependent P/Q-type calcium channel subunit alpha-1A | O00555 |
| CACNA1G | Voltage-dependent T-type calcium channel subunit alpha-1G | O43497 |
| CACNG3 | Voltage-dependent calcium channel gamma-3 subunit | O60359 |
| CACNA1F | Voltage-dependent L-type calcium channel subunit alpha-1F | O60840 |
| CACNA1H | Voltage-dependent T-type calcium channel subunit alpha-1H | O95180 |
| CACNB3 | Voltage-dependent L-type calcium channel subunit beta-3 | P54284 |
| CACNA2D1 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | P54289 |
| CACNG7 | Voltage-dependent calcium channel gamma-7 subunit | P62955 |
| CACNA1B | Voltage-dependent N-type calcium channel subunit alpha-1B | Q00975 |
| CACNA1D | Voltage-dependent L-type calcium channel subunit alpha-1D | Q01668 |
| CACNB1 | Voltage-dependent L-type calcium channel subunit beta-1 | Q02641 |
| CACNG1 | Voltage-dependent calcium channel gamma-1 subunit | Q06432 |
| CACNB2 | Voltage-dependent L-type calcium channel subunit beta-2 | Q08289 |
| CACNA1S | Voltage-dependent L-type calcium channel subunit alpha-1S | Q13698 |
| CACNA1C | Voltage-dependent L-type calcium channel subunit alpha-1C | Q13936 |
| CACNA1E | Voltage-dependent R-type calcium channel subunit alpha-1E | Q15878 |
| CACNA2D4 | Voltage-dependent calcium channel subunit alpha-2/delta-4 | Q7Z3S7 |
| CACNA2D3 | Voltage-dependent calcium channel subunit alpha-2/delta-3 | Q8IZS8 |
| CACNG8 | Voltage-dependent calcium channel gamma-8 subunit | Q8WXS5 |
| CACNG6 | Voltage-dependent calcium channel gamma-6 subunit | Q9BXT2 |
| CACNA2D2 | Voltage-dependent calcium channel subunit alpha-2/delta-2 | Q9NY47 |
| CACNA1I | Voltage-dependent T-type calcium channel subunit alpha-1I | Q9P0X4 |
| CACNG4 | Voltage-dependent calcium channel gamma-4 subunit | Q9UBN1 |
| CACNG5 | Voltage-dependent calcium channel gamma-5 subunit | Q9UF02 |
| CACNG2 | Voltage-dependent calcium channel gamma-2 subunit | Q9Y698 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 2 | 2 | 0 | 0 |
| All trials | 2 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Yuhan | Lead sponsor of trials | 2017 to now |